Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study

In the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial, patients received intravenous recombinant tissue-type plasminogen activator (rt-PA) and were randomized to either a conservative or an invasive strategy. Within this study, the effects of immediate versus deferred beta-blocker thera...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 1991-02, Vol.83 (2), p.422-437
Hauptverfasser:	Roberts, R, Rogers, W J, Mueller, H S, Lambrew, C T, Diver, D J, Smith, H C, Willerson, J T, Knatterud, G L, Forman, S, Passamani, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Female Humans Male Metoprolol - therapeutic use Middle Aged Myocardial Infarction - drug therapy Myocardial Infarction - mortality Risk Factors Thrombolytic Therapy Time Factors Tissue Plasminogen Activator - therapeutic use Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!